Skip to main content

Table 1 Baseline clinical characteristics of enrolled patients

From: Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment

Characteristic

Value

Patients enrolled (n)

704

 Variceal bleeding

581

 Refractory ascites

72

 Variceal bleeding and refractory ascites

51

Age, years, (mean ± SD)

53.2 ± 13.6

Gender, male/female, (n)

511/193

Cause of cirrhosis (n)

 

 HBV

509

 HCV

134

 HBV + HCV

52

 HBV + HDV

9

Child-Pugh classification (n)

 

 A

219

 B

421

 C

64

MELD score, (mean ± SD)

12.8 ± 5.1

Stiffness of liver, KPa, (mean ± SD)

18.6 ± 10.7

Diameter of portal vein, cm, (mean ± SD)

1.52 ± 0.37

Diameter of splenic vein, cm, (mean ± SD)

0.96 ± 0.21

  1. MELD model for end-stage liver disease